Cabaletta Bio (CABA) Other Non-Current Assets (2019 - 2025)
Cabaletta Bio's quarterly Other Non-Current Assets came in at $5.2 million in Q4 2025, up 124.99% year-on-year from $2.3 million in Q4 2024, and up 43.03% quarter-over-quarter from $3.6 million in Q3 2025.
Cabaletta Bio has reported Other Non-Current Assets for 7 years, with the latest figure at $5.2 million in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets rose 124.99% year-over-year to $5.2 million; the trailing twelve-month figure through Dec 2025 stood at $5.2 million (up 124.99% YoY), and the FY2025 full-year result was $5.2 million, up 124.99% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $5.2 million, up from $3.6 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $5.2 million in Q4 2025, with the low at $300000.0 in Q1 2021.
- Average Other Non-Current Assets over 5 years is $1.6 million, with a median of $984500.0 recorded in 2022.
- Year-over-year, Other Non-Current Assets sank 41.02% in 2023 and surged 307.57% in 2024.
- Tracing CABA's Other Non-Current Assets over 5 years: stood at $357000.0 in 2021, then jumped by 58.26% to $565000.0 in 2022, then jumped by 202.48% to $1.7 million in 2023, then soared by 34.17% to $2.3 million in 2024, then jumped by 124.99% to $5.2 million in 2025.
- The last three Other Non-Current Assets figures came in at $5.2 million (Q4 2025), $3.6 million (Q3 2025), and $2.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - | 5.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.16 Mn |
| Sep 30, 2025 | 3.61 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Mar 31, 2025 | 2.37 Mn |
| Dec 31, 2024 | 2.29 Mn |
| Sep 30, 2024 | 2.48 Mn |
| Jun 30, 2024 | 2.25 Mn |
| Mar 31, 2024 | 2.37 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | 984,000.00 |
| Jun 30, 2023 | 685,000.00 |
| Mar 31, 2023 | 581,000.00 |
| Dec 31, 2022 | 565,000.00 |
| Sep 30, 2022 | 689,000.00 |
| Jun 30, 2022 | 965,000.00 |
| Mar 31, 2022 | 985,000.00 |
| Dec 31, 2021 | 357,000.00 |
| Sep 30, 2021 | 324,000.00 |
| Jun 30, 2021 | 318,000.00 |
| Mar 31, 2021 | 300,000.00 |
| Dec 31, 2020 | 299,000.00 |
| Sep 30, 2020 | 239,000.00 |
| Jun 30, 2020 | 238,000.00 |
| Mar 31, 2020 | 104,000.00 |
| Dec 31, 2019 | 101,000.00 |
| Sep 30, 2019 | 91,000.00 |